Industrial manufacturing company Ingersoll Rand (NYSE: IR) announced better-than-expected revenue in Q4 CY2025, with sales up 10.1% year on year to $2.09 billion. Its non-GAAP profit of $0.96 per share was 6.6% above analysts’ consensus estimates.

Is now the time to buy IR? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Ingersoll Rand’s fourth quarter was met with a positive market reaction, as the company’s revenue and non-GAAP earnings per share both exceeded Wall Street expectations. Management attributed this performance to continued expansion in recurring revenue streams, disciplined execution of its M&A strategy, and resilient order growth across key business segments. CEO Vicente Reynal highlighted that recurring revenue surpassed $450 million in 2025, supported by a robust $1.1 billion backlog, while recent acquisitions added scale and technological capability. Reynal emphasized, “Our teams remain nimble through the use of IRX and continue to leverage our economic growth engine to outperform in the markets in which we serve.”

Looking forward, Ingersoll Rand’s guidance for the upcoming year reflects cautious optimism, with management expecting moderate organic growth and a focus on maintaining stable margins amid ongoing tariff-related headwinds. The company is banking on continued momentum in life sciences, expansion of its recurring revenue model, and productivity initiatives to offset cost pressures. CFO Vikram U. Kini noted, “We expect price/cost to be positive for the full year,” but also cautioned that margin expansion will likely be weighted toward the second half as pricing actions and productivity measures take effect. Management remains vigilant on broader industrial trends, particularly monitoring signs of inflection in short-cycle markets and decision-making cycles for long-term projects.

Key Insights from Management’s Remarks

Management pointed to recurring revenue gains, disciplined M&A, and strategic product innovation as primary drivers of Q4 performance, while highlighting ongoing tariff impacts on margins.

• Recurring revenue expansion: The company’s recurring revenue streams grew to over $450 million, with a backlog of $1.1 billion, driven by service contracts and aftermarket solutions. Management indicated this is foundational for long-term stability and margin strength, particularly as these revenues tend to be higher margin and less cyclical than equipment sales.
• M&A activity remains robust: Ingersoll Rand completed 16 acquisitions in 2025, investing $525 million and adding $275 million in annualized inorganic revenue. Management described its acquisition pipeline as “robust,” with a mix of bolt-on deals and potential larger transactions, while maintaining discipline on purchase multiples and integration.
• Life sciences momentum: The Precision and Science Technologies (PST) segment posted mid-teens organic order growth in life sciences, led by demand for pharmaceutical and biopharma production equipment. Management credited recent acquisitions, such as Synomics and the EasyJetFlow mixer, for enhancing its offering and driving customer wins.
• Product innovation fuels energy efficiency: Recent product launches, such as the advanced aeration technology for wastewater applications, are designed to deliver tangible customer benefits like up to 34% energy savings. Management expects these innovations to expand aftermarket and service opportunities, supporting recurring revenue goals.
• Margin pressure from tariffs and investment: Adjusted EBITDA margins contracted year over year due to the impact of tariffs and deliberate commercial investments for growth. Management expects continued pressure in the first half of the year, with recovery anticipated as pricing and productivity measures ramp up.

Drivers of Future Performance

Management’s outlook for the next year is shaped by recurring revenue growth, life sciences expansion, and ongoing margin management in the face of external cost pressures.

• Recurring revenue and aftermarket services: Management expects recurring revenue to continue driving stability and higher margins, as contracts signed in prior years convert to revenue and new service offerings are rolled out. The $1.1 billion backlog offers visibility and underpins guidance.
• Life sciences and innovation: The PST segment is projected to sustain momentum, fueled by demand for life sciences solutions, ongoing product launches, and the integration of recent bolt-on acquisitions. Management believes these factors will help offset tougher year-over-year comparisons and support mid-single-digit earnings growth.
• Margin headwinds and cost actions: Tariff-related costs and increased commercial investments are expected to weigh on margins, especially in the first half of the year. Management plans to mitigate these pressures through pricing actions, productivity improvements, and restructuring measures, with the benefits becoming more apparent in the latter half of the year.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will be watching (1) the trajectory of recurring revenue and backlog conversion into reported sales, (2) the integration and performance of recent acquisitions, especially Synomics, and (3) sustained order momentum in life sciences and aftermarket segments. Margin stabilization as tariff impacts diminish and the realization of productivity initiatives will also be critical signposts for execution.

Ingersoll Rand currently trades at $98.85, up from $94.21 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.